Solifenacin succinate (VESIcare): overactive bladder therapy.
Kosier
June Hannay
JH
Reed Group, East Greenbush, NY, USA.
Combest
Wendell
W
Newton
Marian
M
D000075202:Contraindications; D006801:Humans; D018727:Muscarinic Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D011812:Quinuclidines / Q000009:adverse effects / Q000494:pharmacology*; D000069464:Solifenacin Succinate; D044005:Tetrahydroisoquinolines / Q000009:adverse effects / Q000494:pharmacology*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000451:nursing
D018727:Muscarinic Antagonists; D011812:Quinuclidines; D044005:Tetrahydroisoquinolines; D000069464:Solifenacin Succinate